Combined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric cases

Springer Science and Business Media LLC - Tập 69 Số 1 - 2021
Tarek Hamed1, Dina Sarhan1
1Pediatric Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Tóm tắt

Abstract Background Initial reports from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic described children as being less susceptible to coronavirus disease (COVID-19) than adults. Later on, a severe and novel pediatric disorder termed multisystem inflammatory syndrome in children (MIS-C) emerged. Pediatric patients with SARS-CoV-2 are at risk for critical illness with severe pulmonary COVID-19 and MIS-C. Both are described as two distinct conditions, and the differentiation between them was the scope of many studies. In this report from Egypt, we will describe two unique pediatric cases presented by combined manifestations of severe pulmonary COVID-19 and MIS-C. Case presentation Two patients presented with severe pulmonary COVID-19 evident by pulmonary symptoms, signs, and advanced CO-RADS stage in lung CT were simultaneously fulfilling the clinical criteria of MIS-C including fever, multi-system affection, increased inflammatory markers in addition to the proved COVID-19 by positive serologic tests for SARS-CoV-2 but PCR was negative. Both patients responded well to immune-modulation therapy by IVIG and steroids and discharged well under closed follow-up. Conclusions Although it is debatable to present simultaneously, MIS-C should be considered in patients presenting with typical clinical findings and concerns for pulmonary COVID-19 once the criteria for MIS-C diagnosis is fulfilled. Starting treatment without delay can favor better prognosis.

Từ khóa


Tài liệu tham khảo

Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 395:1771

Royal College of Paediatrics and Child Health Guidance: Paediatric multisystem inflammatory syndrome temporally associated with COVID-19, Available from: https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.

Simon Junior H, Sakano TMS, Rodrigues RM, Eisencraft AP, Carvalho VEL, Schvartsman C et al (2020) Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician’s point of view. J Pediatr (Rio J) (97):140–159 doi.org/10.1016/j.jped.2020.08.004

Centers for Disease Control and Prevention. Emergency preparedness and response: Health Alert network. [May 14, 2020]. Available from: https://emergency.cdc.gov/han/2020/han00432.asp.

Multisystem inflammatory syndrome in children and adolescents with COVID-19. 15 May 2020 Scientific brief: World Health Organisation. Available from: https://www.who.int/publications-detail/multisystem-inflammatory-syndrome-in-children-andadolescents-with-covid-19.

García-Salido A, de Carlos Vicente JC, Hofheinz SB, Ramírez JB, Barrio MS et al (2020) Severe manifestations of SARS-CoV-2 in children and adolescents. From COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. Crit Care 24(666). https://doi.org/10.1186/s13054-020-03332-4

Diorio C, Henrickson SE, Vella LA, McNerney KO, Chase J, Burudpakdee C et al (2020) Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2. J Clin Invest 130(11):5967–5975

Rowley AH (2020) Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nat Rev Immunol 20(8):453–454. https://doi.org/10.1038/s41577-020-0367-5

Rowley AH, Shulman ST, Arditi M (2020) Immune pathogenesis of COVID-19–related multisystem inflammatory syndrome in children. J Clin Invest 130(11):5619–5621. https://doi.org/10.1172/JCI143840

Swann OV, Holden KA, Turtle L, Pollock L, Fairfield CJ, Drake TM et al (2020) Clinical characteristics of children and young people admitted to hospital with COVID-19 in United Kingdom: prospective multicentre observational cohort study. BMJ 370:m3249

Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF et al (2020) Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 383:334–346

Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G et al (2020) Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health 4:669–677

Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S (2020) Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel) 7(7):69. https://doi.org/10.3390/children7070069

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 69 Số 1

Thông tin tác giả